Anna Maria Geretti

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Men Who Have Sex With Men

Antiretroviral Therapy

Hepatitis C Virus

Top Venues

The Journal of antimicrobial chemotherapy

Scientific reports

Sexually transmitted infections

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro, Anna Maria Geretti
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro, Anna Maria Geretti
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro, Anna Maria Geretti
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Ludovica Ferrari, Alessandra Ruggiero, Chiara Stefani, Livia Benedetti, Lorenzo Piermatteo, Eleonora Andreassi, Federica Caldara, Drieda Zace, Matteo Pagliari, Francesca Ceccherini-Silberstein, Christopher Jones, Marco Iannetta, Anna Maria Geretti, null null
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection. Scientific reports 14 (1) (2024)
Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro, Anna Maria Geretti
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro, Anna Maria Geretti
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Ludovica Ferrari, Alessandra Ruggiero, Chiara Stefani, Livia Benedetti, Lorenzo Piermatteo, Eleonora Andreassi, Federica Caldara, Drieda Zace, Matteo Pagliari, Francesca Ceccherini-Silberstein, Christopher Jones, Marco Iannetta, Anna Maria Geretti, null null
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection. Scientific reports 14 (1) (2024)
Ludovica Ferrari, Alessandra Ruggiero, Chiara Stefani, Livia Benedetti, Lorenzo Piermatteo, Eleonora Andreassi, Federica Caldara, Drieda Zace, Matteo Pagliari, Francesca Ceccherini-Silberstein, Christopher Jones, Marco Iannetta, Anna Maria Geretti, null null
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection. Scientific reports 14 (1) (2024)
Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro, Anna Maria Geretti
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro, Anna Maria Geretti
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. The Journal of antimicrobial chemotherapy (2023)
Anna Maria Geretti, Otilia Mardh, Henry J C de Vries, Andrew J Winter, John McSorley, Nicole Seguy, Bea Vuylsteke, Deniz Gokengin
Sexual transmission of infections across Europe: appraising the present, scoping the future. Sexually transmitted infections (2022)
Anna Maria Geretti, Jose Luis Blanco, Anne Genevieve Marcelin, Carlo Federico Perno, Hans Jurgen Stellbrink, Dan Turner, Tuba Zengin
HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance. Infectious diseases and therapy 11 (5) (2022)
Giovanni Villa, Dorcas Ohui Owusu, Colette Smith, Marilyn Azumah, Adam Abdullahi, Suzannah Phillips, Laila Sayeed, Harrison Austin, David Chadwick, Richard Odame Phillips, Anna Maria Geretti
Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfection. Hepatology communications 6 (11) (2022)
Stefano Rusconi, Weiming Tang, Anna Maria Geretti
Research news in clinical context. Sexually transmitted infections 97 (7) (2021)